NEW YORK (GenomeWeb News) - Millipore yesterday said third-quarter revenues increased 12 percent as R&D spending swelled 8 percent and profit shot up nearly 150 percent.
 
Total receipts for the three months ended Sept. 29 increased to $371.2 million from $330.1 million year over year.
 
Sales in the company's Bioprocess segment rose 8 percent to $210.5 million, while Bioscience revenue rose 19 percent to $160.7 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.